NCT03640507

Brief Summary

The purpose of this study is to see whether chlorhexidine is superior to povidine-iodine vaginal antisepsis at reducing bacteria colony counts in pregnant women by comparing three groups: vaginal washing with chlorhexidine-alcohol, vaginal washing with povidine-iodine, and vaginal washing with saline alone.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Oct 2018

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 17, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 21, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2018

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 8, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 14, 2019

Completed
12 months until next milestone

Results Posted

Study results publicly available

June 9, 2020

Completed
Last Updated

June 9, 2020

Status Verified

May 1, 2020

Enrollment Period

7 months

First QC Date

August 17, 2018

Results QC Date

May 14, 2020

Last Update Submit

May 29, 2020

Conditions

Keywords

vaginal preparationantisepsisC-section

Outcome Measures

Primary Outcomes (2)

  • Post-intervention Aerobic Bacterial Colony Counts

    Vaginal cultures are collected after the vaginal preparation intervention. These undergo serial dilutions and are incubated on Tryptic Soy Agar for seven days. Bacteria colony counts were determined by blinded investigators on day 7.

    From intervention to 7 days post

  • Post-intervention Anaerobic Bacterial Colony Counts

    Vaginal cultures are collected after the vaginal preparation intervention. These undergo serial dilutions and are incubated on Tryptic Soy Agar for seven days. Bacteria colony counts were determined by blinded investigators on day 7.

    From intervention to 7 days post

Secondary Outcomes (2)

  • Baseline Aerobic Bacterial Colony Counts

    From intervention to 7 days post

  • Baseline Anaerobic Bacterial Colony Counts

    From intervention to 7 days post

Other Outcomes (1)

  • Number of Participants Diagnosed With Postpartum Infections.

    Up to six weeks postpartum

Study Arms (3)

Chlorhexidine-alcohol

ACTIVE COMPARATOR

Subjects will receive vaginal preparation with chlorhexidine-alcohol.

Drug: Chlorhexidine-alcohol

Povidine-iodine

ACTIVE COMPARATOR

Subjects will receive vaginal preparation with povidine-iodine.

Drug: Povidine-iodine

Saline

PLACEBO COMPARATOR

Subjects will receive vaginal preparation with sterile saline.

Drug: Sterile saline

Interventions

Intervention is a 30-second vaginal preparation or topical wash with three chlorhexidine-alcohol 0.5% solution-soaked sponge sticks.

Also known as: Chlorohexidine Gluconate (CHG)
Chlorhexidine-alcohol

Intervention is a 30-second vaginal preparation or topical wash with three povidine-iodine 10% solution-soaked sponge sticks.

Also known as: Betadine
Povidine-iodine

Intervention is a 30-second vaginal preparation or topical wash with three sterile saline-soaked sponge sticks.

Also known as: Sodium chloride 0.9%
Saline

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pregnant women admitted for cesarean delivery
  • Gestational age greater than or equal to 34 weeks

You may not qualify if:

  • Rupture of membranes or active labor
  • Chorioamnionitis (prior to enrollment)
  • Recent (within 4 weeks) antibiotic exposure
  • Maternal HIV infection or immunocompromised state
  • Known allergy to shellfish, iodine, or chlorhexidine

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

New York Presbyterian Hospital at Columbia University and Children's Hospital of New York

New York, New York, 10032, United States

Location

Related Publications (2)

  • Duffy CR, Garcia-So J, Ajemian B, Gyamfi-Bannerman C, Han YW. A randomized trial of the bactericidal effects of chlorhexidine vs povidone-iodine vaginal preparation. Am J Obstet Gynecol MFM. 2020 Aug;2(3):100114. doi: 10.1016/j.ajogmf.2020.100114. Epub 2020 Apr 15.

  • Haas DM, Morgan S, Contreras K, Kimball S. Vaginal preparation with antiseptic solution before cesarean section for preventing postoperative infections. Cochrane Database Syst Rev. 2020 Apr 26;4(4):CD007892. doi: 10.1002/14651858.CD007892.pub7.

MeSH Terms

Conditions

InfectionsSurgical Wound Infection

Interventions

ChlorhexidineEthanolPovidone-IodineSodium Chloride

Condition Hierarchy (Ancestors)

Wound InfectionPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

BiguanidesGuanidinesAmidinesOrganic ChemicalsAlcoholsIodophorsIodine CompoundsInorganic ChemicalsPolyvinylsVinyl CompoundsAlkenesHydrocarbons, AcyclicHydrocarbonsPovidonePyrrolidinonesPyrrolidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsPlasticsPolymersMacromolecular SubstancesBiomedical and Dental MaterialsManufactured MaterialsTechnology, Industry, and AgricultureChloridesHydrochloric AcidChlorine CompoundsSodium Compounds

Limitations and Caveats

Small sample size.

Results Point of Contact

Title
Cassandra R. Duffy, MD, MPH
Organization
Beth Israel Deaconess Medical Center

Study Officials

  • Yiping Han, PhD

    Columbia University Department of Microbiology and Immunology

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Microbial Sciences

Study Record Dates

First Submitted

August 17, 2018

First Posted

August 21, 2018

Study Start

October 1, 2018

Primary Completion

May 8, 2019

Study Completion

June 14, 2019

Last Updated

June 9, 2020

Results First Posted

June 9, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

Locations